Literature DB >> 15379764

Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.

B Yazdani-Biuki, H Stelzl, H P Brezinschek, J Hermann, T Mueller, P Krippl, W Graninger, T C Wascher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15379764     DOI： 10.1111/j.1365-2362.2004.01390.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  40 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.

Authors:  Frank C Huvers; Calin Popa; Mihai G Netea; Frank H J van den Hoogen; Cees J Tack
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

Review 3.  Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.

Authors:  Allison B Goldfine; Steven E Shoelson
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 4.  Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions.

Authors:  Nicholas P Hays; Pietro R Galassetti; Robert H Coker
Journal:  Pharmacol Ther       Date:  2008-03-02       Impact factor: 12.310

5.  PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance.

Authors:  Barbara Becattini; Romina Marone; Fabio Zani; Denis Arsenijevic; Josiane Seydoux; Jean-Pierre Montani; Abdul G Dulloo; Bernard Thorens; Frédéric Preitner; Matthias P Wymann; Giovanni Solinas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 6.  BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.

Authors:  Dequina A Nicholas; Guillaume Andrieu; Katherine J Strissel; Barbara S Nikolajczyk; Gerald V Denis
Journal:  Cell Mol Life Sci       Date:  2016-08-04       Impact factor: 9.261

Review 7.  Targeting inflammation in the treatment of type 2 diabetes: time to start.

Authors:  Marc Y Donath
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

8.  Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells.

Authors:  Michael C Lawrence; Bashoo Naziruddin; Marlon F Levy; Andrew Jackson; Kathleen McGlynn
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

Review 9.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 10.  The outliers become a stampede as immunometabolism reaches a tipping point.

Authors:  Barbara S Nikolajczyk; Madhumita Jagannathan-Bogdan; Gerald V Denis
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.